Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: China-US Trade Talks Positive But Lower Call

Mon, 18th Nov 2019 07:42

(Alliance News) - Stock prices in London were set to open marginally lower on Monday, with investors unmoved by the latest hints US and China trade reconciliation, and amid uncertainty about US President Donald Trump's policy on auto-part imports from the European Union.

IG futures indicate the FTSE 100 index is to open 3.0 points lower at 7,300.3. The blue-chip index closed up 10.18 points, or 0.1%, on Friday at 7,302.94, ending the week down 0.8%.

"European stocks are expected to kick off a new week a little flat on Monday, with more talks between the US and China failing to excite investors in the way they have been recently," OANDA market analyst Craig Erlam said.

Top Chinese and US trade negotiators held "constructive" discussions over the phone on a preliminary trade deal between the two countries, China's commerce ministry announced in a statement on Sunday.

The long-running trade war between Washington and Beijing has weighed on the global economy and spooked markets, with the two sides imposing punitive tariffs on hundreds of billions of dollars in two-way trade.

US President Trump announced a "phase one" trade deal last month which has yet to be signed.

Vice Premier Liu He spoke with US Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin on Saturday, and had "constructive discussion on each side's core concerns regarding the phase-one agreement", the Chinese commerce ministry said.

The two sides will "continue to maintain close communication", it added, without providing further details.

The Japanese Nikkei 225 index closed 0.5% higher on Monday. In China, the Shanghai Composite ended up 0.6%, while the Hang Seng index in Hong Kong is up 1.3%.

In the US on Friday, stocks ended in the green, the Dow Jones Industrial Average and S&P 500 both 0.8% higher and the Nasdaq Composite up 0.7%.

Last week, a combative US president hit out at the trading bloc, labelling the European Union's barriers "very, very difficult".

According to AFP, the delay on a decision on whether to slap tariffs on auto parts imported from the European Union could last for another six months.

"Donald Trump hasn't made a decision in relation to EU auto tariffs, and that is acting as a cap to eurozone equity benchmarks. The chatter last week was the US leader would defer the decision to impose tariffs by six months. Trump might be saving the EU economic war for his campaign trail next year," CMC Markets analyst David Madden commented.

In the FTSE 100, accounting software firm Sage Group said it will secure GBP232 million from the sale of a subsidiary to global payments company Elavon.

The disposal of Sage Pay, which generated revenue of GBP41 million last year, is subject to Elavon securing approval from US regulators.

Technical products and services firm Diploma reported full-year revenue growth of 12% to GBP544.7 million.

The FTSE 250 firm's pretax profit stretched 15% year-on-year to GBP83.5 million, and Diploma upped its full-year dividend to 29.0 pence per share from 25.5p.

Looking ahead, Diploma said: "Despite the uncertain political and economic environment impacting industrial markets, the board remains confident of further progress in the current financial year as moderately lower underlying growth will be offset by a strong contribution from acquisitions."

Diploma spent GBP78.3 million, a record investment, on acquisitions in the year ended September 30.

M&A activity continued on Monday, following a busy day for the London market on Friday, which saw Amerisur Resources, Carpetright and Eddie Stobart Logistics all agreeing to purchases.

On Monday, Consort Medical was subject to a takeover bid from a subsidiary of Swedish pharmaceutical firm Recipharm AB.

Recipharm will acquire the London-listed medical devices maker for GBP505 million, paying 1,010p for each Consort share, about a 40% premium. The deal gives the company an enterprise value of GBP627 million, including debt.

In the US, the National Association of Home Builders' housing market index for November is published at 1400 GMT.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

More News
29 Aug 2018 16:14

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 30 AugustFIH GroupCreightonsSophos GroupFriday 31 3 4 Investment 5

Read more
23 Aug 2018 17:32

Schroders Cuts Consort Medical Stake To Below 5% After Deal (ALLISS)

LONDON (Alliance News) - Consort Medical PLC said Thursday that Schroders PLC decreased its stake in the drug and delivery device manufacturer to below 5% after a transaction on holding after the

Read more
7 Aug 2018 14:50

Axxion Holds 6.0% Interest In Carclo After Transaction (ALLISS)

LONDON (Alliance News) - Plastic products firm Carclo PLC on Tuesday said Axxion SA now holds a 6.0% interest in the company after a transaction on Monday.Prior to that, Axxion's was on

Read more
7 Aug 2018 10:37

WINNERS & LOSERS SUMMARY: Domino's Pizza Slumps As Profit Falls

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - WINNERS----------Standard Life

Read more
7 Aug 2018 09:57

Carclo Shares Drop 20% As Consort Medical Withdraws From Making Offer

LONDON (Alliance News) - Medical devices manufacturer Consort Medical PLC said Tuesday it does not intend to make an offer for industry peer Carclo PLC.Carclo shares were down 20% at 93.69

Read more
1 Aug 2018 12:20

James Cropper Appoints RHI Magnesita Non-Executive Hosty To Board

LONDON (Alliance News) - Paper products manufacturer James Cropper PLC said Wednesday that Andrew Hosty will join as non-executive director with immediate effect.Hosty has been an acting to

Read more
23 Jul 2018 10:23

Consort Medical Gets Extension To Make Firm Offer For Carclo

LONDON (Alliance News) - Plastic products maker Carclo PLC said Monday it has secured an extension to the deadline for Consort Medical PLC to make a firm offer for the company.The Panel on

Read more
2 Jul 2018 13:36

UPDATE: Carclo Rejects Takeover Approach By Consort Medical

LONDON (Alliance News) - Drug and medical device company Consort Medical PLC said Monday that plastics products maker Carclo PLC has rejected its non-binding acquisition proposal.Consort of

Read more
2 Jul 2018 10:58

WINNERS & LOSERS SUMMARY: Playtech Sinks On Asia Profit Warning

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Micro Focus up

Read more
2 Jul 2018 09:57

Carclo Rejects Takeover Approach By Consort Medical

LONDON (Alliance News) - Drug and medical device company Consort Medical PLC said Monday that plastics products maker Carclo PLC has rejected its non-binding acquisition proposal.Consort of

Read more
14 Jun 2018 11:40

Consort Medical Annual Revenue Rises But Profit Slips On Restructuring

LONDON (Alliance News) - Consort Medical PLC on Thursday said it delivered a good growth across all of its divisions in its recently ended financial year, but profit fell on restructuring company

Read more
14 Jun 2018 09:33

BROKER RATINGS SUMMARY: UBS Cuts RELX; Barclays Cuts Pearson

LONDON (Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:----------FTSE 100----------UBS CUTS TO CUTS TO - TO

Read more
10 Feb 2017 16:12

UK Dividends Calendar - Next 7 Days

Read more
23 Jan 2017 15:23

Consort Medical pours more cash into Atlas Genetics

(ShareCast News) - Single-source drug and delivery device company Consort Medical announced on Monday that it has participated in a further equity raise by Atlas Genetics. The London-listed firm said that, following the successful CE-marking for the chlamydia trachomatis 'io' test cartridge, Atlas G

Read more
5 Jan 2017 13:29

UPDATE 2-BAT quits nicotine inhaler to focus on vaping

* BAT to transfer Voke rights back to Kind Consumer * Kind to search for new partners * BAT to concentrate efforts on vaping, tobacco-heating (Adds market data, background, byline) By Martinne Geller LONDON, Jan 5 (Reuters) - British American Tobacco (BAT) has quit plan

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.